| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunovant, Inc. (IMVT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $50.51M | - | |
| CFO | 247.6K | $9.62M | -10,000 | |
| COO | 224.4K | $8.72M | -17,714 | |
| Other | 218.4K | $8.49M | -40,000 | |
| Other | 218.0K | $8.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 4,042 | $29.65 | $119,845.30 | -1.1% | +6.6% | -50.7% | |
| May 22, 2024 | Salzmann Peter51 | Chief Executive Officer | Sell | 16,163 | $29.65 | $479,232.95 | -1.5% | +6.6% | -50.7% | |
| May 22, 2024 | Butchko Julia G.46 | Chief Development Officer | Sell | 3,247 | $29.65 | $96,273.55 | -0.7% | +6.6% | -50.7% | |
| May 22, 2024 | MacIas William L.51 | Chief Medical Officer | Sell | 3,247 | $29.65 | $96,273.55 | -0.9% | +6.6% | -50.7% | |
| May 22, 2024 | Levine Mark S.66 | Chief Legal Officer | Sell | 3,242 | $29.65 | $96,125.30 | -0.9% | +6.6% | -50.7% | |
| Apr 24, 2024 | Geffner Michael66 | Chief Medical Officer | Sell | 3,261 | $28.90 | $94,242.90 | -2.3% | -2.8% | -47.7% | |
| Apr 24, 2024 | Stout Jay S63 | Chief Technology Officer | Sell | 7,239 | $28.90 | $209,207.10 | -4.7% | -2.8% | -47.7% | |
| Apr 24, 2024 | Levine Mark S.66 | Chief Legal Officer | Sell | 3,963 | $28.90 | $114,530.70 | -1.1% | -2.8% | -47.7% | |
| Apr 17, 2024 | Levine Mark S.66 | Chief Legal Officer | Sell | 9,827 | $29.06 | $285,554.10 | -1.4% | +8.8% | -46.7% | |
| Apr 17, 2024 | MacIas William L.51 | Chief Medical Officer | Sell | 8,280 | $29.06 | $240,601.50 | -0.5% | +8.8% | -46.7% |